Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Abstract 614: Transcriptomic analysis of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG-failure

Florus C. De Jong, Teemu D. Laajala, Robert F. Hoedemaeker, Sébastien Rinaldetti, Jolien T. Mensink, Angelique C. Van der Made, Deric K. Van der Schoot, Egbert R. Boevé, Ellen C. Zwarthoff, Joost L. Boormans, Dan Theodorescu, James C. Costello, Tahlita C. Zuiverloon

Cancer Res (2021) 81 (13_Supplement): 614.

https://doi.org/10.1158/1538-7445.AM2021-614

Published: 01 July 2021

View article titled, Abstract 614: Transcriptomic analysis of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG-failure

Journal Articles

Abstract 615: Differential pathway analyses of BCG-treated T1HG bladder cancer using Philips OncoSignal: A pilot study

Florus C. De Jong, Teemu D. Laajala, Robert F. Hoedemaeker, Sébastien Rinaldetti, Jolien T. Mensink, Angelique C. Van Der Made, Deric K. Van der Schoot, Egbert R. Boevé, Ellen C. Zwarthoff, Joost L. Boormans, Dan Theodorescu, James C. Costello, Tahlita C. Zuiverloon

Cancer Res (2021) 81 (13_Supplement): 615.

https://doi.org/10.1158/1538-7445.AM2021-615

Published: 01 July 2021

View article titled, Abstract 615: Differential pathway analyses of BCG-treated T1HG bladder cancer using Philips OncoSignal: A pilot study

Journal Articles

Abstract 2190: Integrative genomic and transcriptomic characterization of metastatic urothelial carcinoma

Maud Rijnders, J Alberto Nakauma-González, Job van Riet, Michiel S. van der Heijden, Jens Voortman, Edwin P. J. G Cuppen, Niven Mehra, Sandra van Wilpe, Sjoukje F. Oosting, L Lucia Rijstenberg, Ellen C. Zwarthoff, Ronald de Wit, Astrid A. van der Veldt, Harmen J. van de Werken, Martijn P. Lolkema, Joost L. Boormans

Cancer Res (2021) 81 (13_Supplement): 2190.

https://doi.org/10.1158/1538-7445.AM2021-2190

Published: 01 July 2021

View article titled, Abstract 2190: Integrative genomic and transcriptomic characterization of metastatic urothelial carcinoma

Journal Articles

Abstract 1932: Cationic amphiphilic drugs as a potential new treatment option for patients with high risk non-muscle invasive bladder cancer

Geertje van der Horst, Arjanneke F. van de Merbel, Eline Ruigrok, Maaike H. van der Mark, Emily Ploeg, Marja Jäätelä, Janneke van Uhm, Rob C. Pelger, Chris H. Bangma, Joost Boormans, Gabri van der Pluijm, Ellen C. Zwarthoff

Cancer Res (2019) 79 (13_Supplement): 1932.

https://doi.org/10.1158/1538-7445.AM2019-1932

Published: 01 July 2019

View article titled, Abstract 1932: Cationic amphiphilic drugs as a potential new treatment option for patients with high risk non-muscle invasive bladder cancer

Journal Articles

Abstract 428: Hypermethylation of GATA2 is validated as a marker of progression in non-muscle invasive bladder cancer

Kim E.M. van Kessel, Kirstin A. van der Keur, Lars Dyrskjøt, Ferran Algaba, Naeromy Welvaart, Willemien Beukers, Ulrika Segersten, Bastian Keck, Tobias Maurer, Tatjana Simic, Marcus Horstmann, Joost L. Boormans, Francisco X. Real, Nuria Malats, Per-Uno Malmström, Torben F. Ørntoft, Ellen C. Zwarthoff

Cancer Res (2016) 76 (14_Supplement): 428.

https://doi.org/10.1158/1538-7445.AM2016-428

Published: 15 July 2016

View article titled, Abstract 428: Hypermethylation of GATA2 is validated as a marker of progression in non-muscle invasive bladder cancer

Journal Articles

Abstract 4614: Mutation detection in urine from bladder cancer patients as non-invasive prognostic tool

Rossana Critelli, Francesca Fasanelli, Manuela B. Assumma, Ellen C. Zwarthoff, Marco Oderda, Silvia Polidoro, Carlotta Sacerdote, Paolo Vineis, Giuseppe Matullo, Alessio Naccarati

Cancer Res (2015) 75 (15_Supplement): 4614.

https://doi.org/10.1158/1538-7445.AM2015-4614

Published: 01 August 2015

View article titled, Abstract 4614: Mutation detection in urine from bladder cancer patients as non-invasive prognostic tool

Journal Articles

Abstract 549: A urine based assay to select patients for initial cystoscopy

Kim E.M. van Kessel, Willemien Beukers, Irene Lurkin, Kirstin A. van der Keur, Lars Dyrskjot, Ulrika Segersten, Torben F. Ørntoft, Nuria Malats, Per-Uno Malmström, Francisco X. Real, Chris H. Bangma, Ellen C. Zwarthoff

Cancer Res (2015) 75 (15_Supplement): 549.

https://doi.org/10.1158/1538-7445.AM2015-549

Published: 01 August 2015

View article titled, Abstract 549: A urine based assay to select patients for initial cystoscopy

Journal Articles

Abstract 4023: Genome-wide analysis of CpG island methylation identified OTX1, OSR1 and ONECUT2 as biomarkers for recurrent bladder cancer detection in voided urine

Raju Kandimalla, Roy Masius, Angela A.G Van Tilborg, Willemien Beukers, Torben Orntoft, Lars Dyrskjot, Chris H. Bangma, Ellen C. Zwarthoff

Cancer Res (2012) 72 (8_Supplement): 4023.

https://doi.org/10.1158/1538-7445.AM2012-4023

Published: 15 April 2012

View article titled, Abstract 4023: Genome-wide analysis of CpG island methylation identified OTX1, OSR1 and ONECUT2 as biomarkers for recurrent bladder cancer detection in voided urine

Journal Articles

Abstract 3012: Genome-wide analysis of CpG island methylation in bladder cancer identifies novel biomarkers for diagnosis, prediction of progression and survival

Raju Kandimalla, Angela A. G. van Tilborg, Lucie C. Kompier, Dominique J.P.M. Stumpel, Chris H. Bangma, Ellen C. Zwarthoff

Cancer Res (2011) 71 (8_Supplement): 3012.

https://doi.org/10.1158/1538-7445.AM2011-3012

Published: 15 April 2011

View article titled, Abstract 3012: Genome-wide analysis of CpG island methylation in bladder cancer identifies novel biomarkers for diagnosis, prediction of progression and survival

Journal Articles

Abstract 2259: Identifying causative genes and prognostic markers for bladder cancer

Angela A.G. Van Tilborg, Jelmar Quist, Lucie C. Kompier, Irene Lurkin, Miriam van Helvoirt, Maximilian Burger, Arndt Hartmann, Ellen C. Zwarthoff

Cancer Res (2011) 71 (8_Supplement): 2259.

https://doi.org/10.1158/1538-7445.AM2011-2259

Published: 15 April 2011

View article titled, Abstract 2259: Identifying causative genes and prognostic markers for bladder cancer

Journal Articles

Abstract LB-313: Development of a non-invasive, multi-analyte assay for the triage of patients presenting with hematuria

Cecilia A. Fernandez, John M. Millholland, Ellen C. Zwarthoff, Kevin R. Loughlin, Adam Feldman, R. Jeffrey Karnes, Anthony P. Shuber

Cancer Res (2011) 71 (8_Supplement): LB-313.

https://doi.org/10.1158/1538-7445.AM2011-LB-313

Published: 15 April 2011

View article titled, Abstract LB-313: Development of a non-invasive, multi-analyte assay for the triage of patients presenting with hematuria

Journal Articles

Abstract 4897: Genome-wide analysis of CGIs in bladder cancer identifies novel epigenetic biomarkers for diagnosis and follow-up

Raju Kandimalla, Angela Van Tilborg, Lucie Kompier, Dominique J.P.M Stumpel, Ellen C. Zwarthoff

Cancer Res (2010) 70 (8_Supplement): 4897.

https://doi.org/10.1158/1538-7445.AM10-4897

Published: 15 April 2010

View article titled, Abstract 4897: Genome-wide analysis of CGIs in bladder cancer identifies novel epigenetic biomarkers for diagnosis and follow-up

Journal Articles

FGFR3 mutations have different effects on disease course in tumors from the bladder, ureter, and renal pelvis

Johanna M. M. Van Oers, Ellen C. Zwarthoff, Ishtiaq Rehman, Abdel-Rahmene Azzouzi, Oliver Cussenot, Mark Meuth, Freddie C. Hamdy, James W. F. Catto

Cancer Res (2006) 66 (8_Supplement): 1059.

Published: 15 April 2006

View article titled, FGFR3 mutations have different effects on disease course in tumors from the bladder, ureter, and renal pelvis

Journal Articles

The stepwise alteration of chromosome 9 in the evolution of bladder tumors affects predominantly one of the two chromosome copies

Lucie C. Kompier, Irene Lurkin, Ellen C. Zwarthoff

Cancer Res (2006) 66 (8_Supplement): 987.

Published: 15 April 2006

View article titled, The stepwise alteration of chromosome 9 in the evolution of bladder tumors affects predominantly one of the two chromosome copies

Journal Articles

Characterization of alternative genetic pathways in the pathogenesis of bladder cancer

Johanna M. M. Van Oers, Peter J. Wild, Elke Rosskopf, Robert Stoehr, Maximilian Burger, Ferdinand Hofstaedter, Theo H. Van der Kwast, Ellen C. Zwarthoff, Arndt Hartmann

Cancer Res (2005) 65 (9_Supplement): 742.

Published: 01 May 2005

View article titled, Characterization of alternative genetic pathways in the pathogenesis of bladder cancer

Journal Articles

Evolution of LOH patterns on chromosome 9 in recurrent bladder tumors in relation to a FGFR3 mutation

Lucie C. Kompier, Madelon N. Van der Aa, Latifa Qoubbane, Irene Lurkin, Antoine Van Exsel, Theo H. Van der Kwast, Ellen C. Zwarthoff

Cancer Res (2005) 65 (9_Supplement): 1347.

Published: 01 May 2005

View article titled, Evolution of LOH patterns on chromosome 9 in recurrent bladder tumors in relation to a FGFR3 mutation

Journal Articles

Variation in chromosomal aberrations and mitotic defects in meningioma subgroups in relation to the NF2 gene

Angela Van Tilborg, Bushra Al Allak, Sandra Velthuizen, Annie De Vries, Max Kros, Cees J. Avezaat, Annelies De Klein, Berna Beverloo, Ellen C. Zwarthoff

Cancer Res (2004) 64 (7_Supplement): 386.

Published: 01 April 2004

View article titled, Variation in chromosomal aberrations and mitotic defects in meningioma subgroups in relation to the NF2 gene

Journal Articles

FGFR3 and p53 mutations characterize alternative genetic pathways in the pathogenesis of bladder cancer

Ellen C. Zwarthoff, Theo H. Van der Kwast, Andre N. Vis, Wim J. Kirkels, Egbert R. Boeve, Adriaan C. Jobsis, Bas W. Van Rhijn

Cancer Res (2004) 64 (7_Supplement): 410.

Published: 01 April 2004

View article titled, FGFR3 and p53 mutations characterize alternative genetic pathways in the pathogenesis of bladder cancer

Journal Articles

FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma

Bas W. G. van Rhijn, Theo H. van der Kwast, André N. Vis, Wim J. Kirkels, Egbert R. Boevé, Adriaan C. Jöbsis, Ellen C. Zwarthoff

Cancer Res (2004) 64 (6): 1911–1914.

https://doi.org/10.1158/0008-5472.CAN-03-2421

Published: 16 March 2004

View article titled, FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma

Journal Articles

The Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Is a Strong Indicator of Superficial Bladder Cancer with Low Recurrence Rate

Bas W. G. van Rhijn, Irene Lurkin, François Radvanyi, Wim J. Kirkels, Theodorus H. van der Kwast, Ellen C. Zwarthoff

Cancer Res (2001) 61 (4): 1265–1268.

Published: 02 February 2001

View article titled, The Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Is a Strong Indicator of Superficial Bladder Cancer with Low Recurrence Rate

NARROW

Abstract 614: Transcriptomic analysis of BCG-treated T1HG bladder cancer patients identifies an EMT-basal subgroup with immune suppressive characteristics at high risk of BCG-failure

Abstract 615: Differential pathway analyses of BCG-treated T1HG bladder cancer using Philips OncoSignal: A pilot study

Abstract 2190: Integrative genomic and transcriptomic characterization of metastatic urothelial carcinoma

Abstract 1932: Cationic amphiphilic drugs as a potential new treatment option for patients with high risk non-muscle invasive bladder cancer

Abstract 428: Hypermethylation of GATA2 is validated as a marker of progression in non-muscle invasive bladder cancer

Abstract 4614: Mutation detection in urine from bladder cancer patients as non-invasive prognostic tool

Abstract 549: A urine based assay to select patients for initial cystoscopy

Abstract 4023: Genome-wide analysis of CpG island methylation identified OTX1, OSR1 and ONECUT2 as biomarkers for recurrent bladder cancer detection in voided urine

Abstract 3012: Genome-wide analysis of CpG island methylation in bladder cancer identifies novel biomarkers for diagnosis, prediction of progression and survival

Abstract 2259: Identifying causative genes and prognostic markers for bladder cancer

Abstract LB-313: Development of a non-invasive, multi-analyte assay for the triage of patients presenting with hematuria

Abstract 4897: Genome-wide analysis of CGIs in bladder cancer identifies novel epigenetic biomarkers for diagnosis and follow-up

FGFR3 mutations have different effects on disease course in tumors from the bladder, ureter, and renal pelvis

The stepwise alteration of chromosome 9 in the evolution of bladder tumors affects predominantly one of the two chromosome copies

Characterization of alternative genetic pathways in the pathogenesis of bladder cancer

Evolution of LOH patterns on chromosome 9 in recurrent bladder tumors in relation to a FGFR3 mutation

Variation in chromosomal aberrations and mitotic defects in meningioma subgroups in relation to the NF2 gene

FGFR3 and p53 mutations characterize alternative genetic pathways in the pathogenesis of bladder cancer

FGFR3 and P53 Characterize Alternative Genetic Pathways in the Pathogenesis of Urothelial Cell Carcinoma

The Fibroblast Growth Factor Receptor 3 (FGFR3) Mutation Is a Strong Indicator of Superficial Bladder Cancer with Low Recurrence Rate

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only